Influence of clenbuterol on mucociliary transport in healthy horses and horses with chronic obstructive pulmonary disease.

The study investigates the impact of the drug clenbuterol on the mucociliary transport system in healthy horses and horses with chronic obstructive pulmonary disease (COPD). The researchers found that clenbuterol significantly improved the mucus transport rate and clearance index in horses with COPD and increased mucus secretion in both healthy and diseased horses.

Methodology

The researchers studied a total of 32 horses: 16 healthy ones and 16 with chronic obstructive pulmonary disease. All the horses went through a procedure where an Indian ink marker in syrup was placed in the mucus layer on the inner wall of the trachea and its displacement was measured at 30 and 60 minutes. The same procedure was then repeated 30 minutes after administering clenbuterol at a dosage of 0.8 microgram/kg body weight.

Results

• The results showed that horses with COPD had a significantly slower mucociliary transport rate compared to the healthy ones.
• After administering clenbuterol, both the mucus transport rate and clearance index saw a significant increase in the diseased horses.
• Further, 60 and 90 minutes post clenbuterol administration, there was a noticeable increase in mucus secretion in both healthy and diseased horses.

Consistency and Reliability of Data

To assess the reliability of the technique and consistency of data, the scientists carried out measurements on five healthy and five diseased horses on two different days. The outcomes did not vary significantly between the two instances, indicating that the method provides reproducible data.

Significance of the Research

The findings of this study are notable for they demonstrate that clenbuterol can potentially serve as a beneficial treatment to improve mucus clearance in horses with COPD. Enhanced mucus clearance can help in reducing the impact of the disease and increasing the quality of life for these horses. However, the fact that clenbuterol also leads to increased mucus secretion, in both healthy and diseased horses, raises a question on its long-term implications that need to be probed further.